Newsroom | 4922 results

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today hosted its 2025 Investor Day at the Company’s global headquarters in Acton, Massachusetts. During the event, Insulet’s executive team outlined the strategic plan and innovation roadmap that is designed to extend its leadership in the fast-growing and significantly underpenetrated global markets for automa...

TOULOUSE, France & FULLERTON, Californie & LISSES, France--(BUSINESS WIRE)--Regulatory News: ABIONYX Pharma, (FR0012616852 – ABNX – éligible PEA PME), société de biotechnologie de nouvelle génération dédiée à la découverte et au développement de thérapies innovantes basées sur la seule apolipoprotéine apoA- I recombinante au monde, et SEBIA, acteur mondial du diagnostic biologique spécialisé, annoncent aujourd’hui un partenariat stratégique exclusif mondial dans le sepsis. De nouveaux tests de...

TOULOUSE, France & FULLERTON, Calif. & LISSES, France--(BUSINESS WIRE)--Regulatory News: ABIONYX Pharma, (FR0012616852 – ABNX – eligible PEA PME), a next-generation biopharma company pioneering a new therapeutic era in sepsis and critical care through its proprietary apoA-I–based technology platform, and SEBIA, a global player in specialized biological diagnostics, today announced an exclusive global strategic partnership in sepsis. New tests for early diagnosis and monitoring of sepsis treatme...

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System for people over the age of 18 with diabetes will launch in the United States on Dec. 1. At initial launch, Dexcom G7 15 Day will be available for users who receive their Dexcom CGM through DME providers. G7 15 Day will also be covered for Medicare beneficiaries and has met the category requirements for therapeutic CGM sy...

LOUISVILLE, Ky.--(BUSINESS WIRE)--The Humana Foundation, the philanthropic arm of Humana Inc. for the past 44 years, today announced the publication of its new issue brief, Senior Food Insecurity in Kentucky: A Growing Public Health Challenge. The brief examines the complex web of challenges the state’s older adults face in accessing nutritious foods and offers a call to action with recommended investments that can help overcome those barriers. Kentucky ranks 46th among all states in overall se...

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the FDA has cleared Dexcom Smart Basal, the first and only CGM-integrated basal insulin dosing optimizer designed for adults with Type 2 diabetes on glargine U-100 long-acting insulin therapy.1 Dexcom Smart Basal will use Dexcom G7 15 Day sensor data and logged doses to calculate personalized daily recommendations to guide users towards a more effective long-acting insulin dose, as...

LAS VEGAS--(BUSINESS WIRE)--Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an emerging biotechnology company focused on developing cellbased therapies for diabetes and age-related disorders, today announced that its 50/50 joint venture (Klothonova) with Austrianova has entered into an exclusive, worldwide License Agreement with Klothea Bio, Inc. The license agreement, effective immediately, grants Klothonova exclusive global rights to develop, manufacture, and commercialize...

MONTRÉAL--(BUSINESS WIRE)--Une nouvelle analyse de l’étude Charge mondiale de la morbidité publiée dans The Lancet en novembre 20251 révèle que l’impact de la maladie rénale chronique (MRC) a augmenté considérablement en trois décennies. Le taux de mortalité qui lui est associé au Canada, en particulier, a augmenté de plus de 70 % depuis 1990, selon le Dr Marcello Tonelli, professeur de médecine à l’Université de Calgary et président de la Société internationale de néphrologie (SIN). « C’est un...

MONTREAL--(BUSINESS WIRE)--A new analysis from the Global Burden of Disease Study published in The Lancet in November 20251, shows that the impact of chronic kidney disease (CKD) has substantially increased over the past three decades. In particular, Canada’s CKD mortality rate rose by more than 70% since 1990 according to Dr. Marcello Tonelli, University of Calgary medical professor and International Society of Nephrology (ISN) President. “This is markedly higher than the global average, and h...

DUBLIN--(BUSINESS WIRE)--The "United Kingdom Diabetic Food Market Report by Products, Distribution Channel, Region and Company Analysis, 2025-2033" report has been added to ResearchAndMarkets.com's offering. The United Kingdom Diabetic Food Market is expected to reach US$ 909.87 million by 2033 from US$ 536.45 million in 2024, with a CAGR of 6.05% from 2025 to 2033 The United Kingdom diabetic food market demonstrates regional diversity, with England leading in adoption, Scotland showing steady...